Luina Bio And XING Technologies Set To Manufacture New And Fast SARS-CoV-2 Diagnostic Kit
13 July 2020 Luina Bio is pleased to announce they have been selected to partner with XING Technologies (Brisbane) to co-develop and manufacture a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) diagnostic kit. The COVID-19 detection technology is…
BioWorld Recognized for Excellence of Information & Intelligence to Biopharmaceutical Industry
13 July 2020 BioWorld™, a part of Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, was recognized last month for excellence in publishing by the Specialized Information Publishers…
PolyNovo hit record US sales in June, announce first sales in UK
10 July 2020 Highlights: -Record US Sales in June -First Sales in UK -FY20 Sales Guidance US June 2020 was a new record sales month in the US. Since the record sales month announced on 7 April PolyNovo…
New Victorian Commissioner Appointed To Southeast Asia
13 July 2020 The Victorian Government will continue its focus on building strong business, trade, investment and cultural relations across the world following the appointment of a new Commissioner for Victoria to Southeast Asia. Rebecca Hall will soon…
Australian universities join forces to tackle inflammatory lung disease
8 July 2020 A new spin-out company, RAGE Biotech, will develop novel therapies designed to help patients with chronic inflammatory lung diseases such as severe asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD), supported by investment from…
MTPConnect to Deliver $47M Diabetes and Cardiovascular Disease Accelerator Program
13 July 2020 The Australian Government has announced that MTPConnect will operate the new $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease. The announcement was made jointly by Hon Greg Hunt MP, the Minister for…
Accelerating diabetes and cardiovascular disease research
13 July 2020 The Morrison Government is backing cutting-edge research into two of the most prominent health conditions that affect millions of Australians – diabetes and cardiovascular disease. The Government will invest $47 million over four years into…
Updates: Senate Hearing for R&D Tax Incentive Bill (July – September 2020)
3 September 2020 A report was released today from the Senate Select Committee on Financial Technology and Regulatory Technology, chaired by Senator Andrew Bragg. This Committee was reviewing tax, regulation, capital and funding, skills and talent, and culture,…
Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer
9 July 2020 BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, today announced that Chad Briscoe, Ph.D. has joined the organization’s leadership team as Chief Scientific Officer. In this role, Dr.…
CSIRO/Doherty Institute Select Recce Compounds for Priority 1 SARS-CoV-2 Antiviral Screening Program
9 July 2020 Highlights: • RECCE® 327 and New RECCE® 529 compounds were selected for their unique mechanism of actions against hyper-mutation, as indicated on bacteria and viruses (respectively) • Testing program will be conducted by CSIRO &…
Introducing BioMelbourne Network CEO Jeff Malone
Included in Insider – Thursday 9 July 2020 Hello, my name is Jeff Malone. I’m very excited to be taking the lead as the new CEO of BioMelbourne Network on 13 July. I bring with me almost 30…
Application granted for OMX Solutions TriFixTM Plating System inclusion on Prostheses List
7 July 2020 OMX Solutions Pty Ltd is delighted to announce the inclusion of its’ latest custom-made medical device (CMMD), the TriFixTM plating system, on the Prostheses List. The Prosthesis List and TriFixTM plating systems listing becomes effective…
